Skip to content
Disclosery

QIMING U.S. VENTURES MANAGEMENT, LLC

Follow

13F filer, CIK 1909617, BELLEVUE, WA

QIMING U.S. VENTURES MANAGEMENT, LLC reported $52,624,162 across 6 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-088978

Period
2024-06-30
Reported value
$52.6M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001104659-24-088978, largest first. % of portfolio is the value over $52,624,162, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: 928,964 shares; 2024Q2: 928,964 shares 928,964$21.1M40.07%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 368,085 shares; 2024Q1: 368,085 shares; 2024Q2: 368,085 shares 368,085$12.5M23.69%0Timeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 641,691 shares; 2024Q1: 741,691 shares; 2024Q2: 741,691 shares 741,691$9.54M18.13%0
HILLEVAX INCHILLEVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 558,923 shares; 2024Q1: 558,923 shares; 2024Q2: 558,923 shares 558,923$8.08M15.36%0
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 686,370 shares; 2024Q1: 412,225 shares; 2024Q2: 412,225 shares 412,225$952K1.81%0Timeline
KEZAR LIFE SCIENCES INCKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 828,711 shares; 2024Q1: 828,711 shares; 2024Q2: 828,711 shares 828,711$497K0.94%0

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-088978 base2024-08-13acceptance time not in the bulk data set